Phantom® TTC Trauma Nail

About Paragon 28

Founded in 2010, Paragon 28 rapidly grew by focusing exclusively on the underserved foot and ankle surgical market, developing a comprehensive portfolio of trauma, bunion, fusion, biologic, and wound care solutions. Its strategic acquisition by Zimmer Biomet in late 2024 for ~$450 million has positioned it to leverage global scale while maintaining its focused brand and innovation culture. The company's future strategy hinges on integrating its SMART28™ digital surgery platform with Zimmer Biomet's resources to drive procedural standardization and data-driven improvements in patient outcomes.

Therapeutic Areas